A Combination of Proatherogenic Single-Nucleotide Polymorphisms Is Associated with Increased Risk of Coronary Artery Disease and Myocardial Infarction in Asian Indians
- 1 September 2009
- journal article
- research article
- Published by Mary Ann Liebert Inc in DNA and Cell Biology
- Vol. 28 (9), 451-460
- https://doi.org/10.1089/dna.2009.0887
Abstract
Common single-nucleotide polymorphisms (SNPs) in genes of lipid metabolism modestly influence plasma low-density lipoprotein cholesterol (LDL-C) and risk of coronary artery disease (CAD). We evaluated a panel of LDL-C–modulating SNPs for potential association with risk of CAD in Asian Indians. Fifteen SNPs of CETP, ABCB1, APOAI, CYP7A1, and HMGCR genes were genotyped in 265 CAD patients and 150 controls of North Indian origin. A proatherogenic genotype score was formulated based on number of alleles associated with LDL-C and was evaluated for association with risk of CAD. We observed 12 SNPs from CETP, APOAI, ABCB1, CYP7A1, and HMGCR genes to be associated with baseline LDL-C and high-density lipoprotein cholesterol levels and increased risk of CAD (p < 0.05). Co-occurrence of three or more risk alleles (proartherogenic genotype score ≥3) was associated with increased risk of CAD and myocardial infarction. Analysis of epistatic interactions revealed CETPTaqIB1B1/405II/APOAI-75GA to be best model of CAD risk prediction in our population. Our study highlights synergistic association of multiple SNPs of lipid pathway with LDL-C levels and risk of CAD, and indicates that co-occurrence of proatherogenic risk alleles may provide incremental information about CAD risk beyond lipid concentrations.Keywords
This publication has 40 references indexed in Scilit:
- Genomewide Association Analysis of Coronary Artery DiseaseNew England Journal of Medicine, 2007
- A Common Allele on Chromosome 9 Associated with Coronary Heart DiseaseScience, 2007
- Combining Information from Common Type 2 Diabetes Risk Polymorphisms Improves Disease PredictionPLoS Medicine, 2006
- Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart DiseaseNew England Journal of Medicine, 2006
- The genetics of heart attackHeart, 2005
- Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery diseaseAmerican Heart Journal, 2005
- Genetic variation in the rate-limiting enzyme in cholesterol catabolism (cholesterol 7α-hydroxylase) influences the progression of atherosclerosis and risk of new clinical eventsClinical Science, 2005
- Cholesteryl Ester Transfer Protein TaqIB Variant, High-Density Lipoprotein Cholesterol Levels, Cardiovascular Risk, and Efficacy of Pravastatin TreatmentCirculation, 2005
- Polymorphisms in the multidrug resistance-1 (MDR1) gene influence the response to atorvastatin treatment in a gender-specific mannerThe American Journal of Cardiology, 2004
- Increased frequency of the rare PstI allele (P2) in a population of CAD patients in Northern GreeceClinical Genetics, 1995